Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in myeloma separates antigen loss from epitope loss, and works w/ ADCs, TCEs and CAR Ts.”
Title: A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma
Authors: Ricardo Ahrens, Kyra Ahrens, Maximilian Al-Bazaz, Lisa Leypoldt, Carsten Bokemeyer, Winfried Alsdorf, Katja Weisel
You can read the full article on Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily.
